» Authors » Tomasz Baron

Tomasz Baron

Explore the profile of Tomasz Baron including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 629
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sigfridsson J, Baron T, Bergsten J, Harms H, Nordstrom J, Kero T, et al.
EJNMMI Res . 2024 Sep; 14(1):85. PMID: 39294533
Background: Cardiac positron emission tomography (PET) offers non-invasive assessment of perfusion and left ventricular (LV) function from a single dynamic scan. However, no prior assessment of mitral regurgitation severity by...
2.
Hopfgarten J, James S, Lindhagen L, Baron T, Stahle E, Christersson C
Eur Heart J Open . 2024 May; 4(3):oeae039. PMID: 38812477
Aims: There is a lack of robust data on the optimal medical treatment of heart failure in patients with severe aortic stenosis, with no randomized controlled trials guiding treatment. The...
3.
Berglund J, Liljeblad M, Baron T
Magn Reson Med . 2024 May; 92(4):1484-1495. PMID: 38725423
Purpose: To develop and evaluate a phase unwrapping method for cine phase contrast MRI based on graph cuts. Methods: A proposed Iterative Graph Cuts method was evaluated in 10 cardiac...
4.
Lenell J, Lindahl B, Erlinge D, Jernberg T, Spaak J, Baron T
Clin Res Cardiol . 2024 Mar; PMID: 38526603
Aims: This study aimed to investigate the additional value of global longitudinal strain (GLS) on top of left ventricular ejection fraction (LVEF) in long-term risk prediction of combined death and...
5.
Salzinger B, Lundwall K, Evans M, Mortberg J, Wallen H, Jernberg T, et al.
Clin Kidney J . 2024 Mar; 17(3):sfae050. PMID: 38524235
Background: The links between chronic kidney disease (CKD) and the high burden of cardiovascular disease remain unclear. We aimed to explore the association between selected inflammatory and angiogenic biomarkers, kidney...
6.
Baron T, Gerovasileiou S, Flachskampf F
Eur Heart J Cardiovasc Imaging . 2023 Jul; 24(10):1343-1351. PMID: 37399510
Heart failure with preserved ejection fraction (HFpEF) traditionally has been characterized as a form of heart failure without therapeutic options, in particular with a lack of response to the established...
7.
Gard A, Lindahl B, Baron T
Heart . 2023 May; 109(20):1533-1541. PMID: 37220934
Objective: Type 2 myocardial infarction (MI) and myocardial injury are common conditions associated with an adverse prognosis. Physicians experience uncertainty how to distinguish these conditions, as well as how to...
8.
Sorensen J, Bergsten J, Baron T, Orndahl L, Kero T, Bjerner T, et al.
J Nucl Med . 2023 Jan; 64(4):645-651. PMID: 36604185
Subjects with asymptomatic moderate-to-severe or severe primary mitral regurgitation are closely observed for signs of progression or symptoms requiring surgical intervention. The role of myocardial metabolic function in progression of...
9.
Mortberg J, Salzinger B, Lundwall K, Edfors R, Jacobson S, Wallen H, et al.
Int J Cardiol . 2022 Dec; 373:64-71. PMID: 36476672
Background: Patients with kidney failure have a high risk for cardiovascular events. We aimed to evaluate the prognostic importance of selected biomarkers related to haemostasis, endothelial function, and vascular regulation...
10.
Flachskampf F, Baron T
J Clin Med . 2022 Oct; 11(20). PMID: 36294522
Heart failure is becoming the central problem in cardiology. Its recognition, differential diagnosis, and the monitoring of therapy are intimately coupled with cardiac imaging. Cardiac imaging has witnessed an explosive...